The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1267 articles
GHK-Cu peptide is gaining significant attention for its potential in skin rejuvenation and anti-aging. This article delves into what GHK-Cu is, why it's popular, and the crucial role of medical oversight in its application, moving beyond online trends to evidence-based practice.
Peptides, the signaling molecules built from amino acids, are emerging as precise tools for targeted wellness, especially as the body's natural production declines after 50. Learn which five peptides can help restore vitality, repair tissue, and combat aging-related inflammation.
Discover how new studies are reshaping our understanding of Type 2 diabetes management with tirzepatide and offering critical insights into the biological drivers of Long COVID's persistent neurological symptoms.
South Africa's regulatory bodies are taking decisive action against the booming market for compounded GLP-1 weight-loss drugs, including versions of Ozempic and Mounjaro. This crackdown highlights significant safety concerns and potential risks to public health.
New research from the NIH reveals how semaglutide signaling in the brain affects weight loss plateaus, offering hope for improved efficacy and dosing strategies.
Discover how natural peptides are challenging the pharmaceutical industry, offering a new paradigm for healing, metabolic health, and cognitive enhancement amidst evolving regulatory landscapes.
GLP-1 receptor agonists have revolutionized weight loss and diabetes management, but researchers are continuously seeking ways to enhance their delivery. This article delves into cutting-edge advancements, from nanocarriers to microneedles, aiming to make these powerful therapies more effective, tolerable, and convenient.
Discover Retatrutide, a groundbreaking peptide with triple-receptor activity, poised to redefine metabolic health and weight management strategies. Learn about its science, potential, and what it means for the future of wellness.
Researchers at the University of Pennsylvania utilized artificial intelligence to analyze hundreds of thousands of Reddit posts, uncovering patient-reported side effects of GLP-1 medications that traditional clinical trials often overlook.
